Clinical Trial Update: NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds [Phase 2]

View source ↗

Summary

Phase 2 trial update for NM-IL-12 (rHuIL-12) in subjects with open surgical wounds (colostomy stoma) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colostomy Stoma

Drugs mentioned

• NM-IL-12 (rHuIL-12) (recombinant human interleukin-12)

Snippet

Sponsor: Neumedicines Inc. | Conditions: Colostomy Stoma | Phase 2 | Status: COMPLETED